Portulaca oleracea inhibit vincristine induced peripheral neuropathy: involvement of ATP-sensitive K+ channels

L. Mohana Rupa, K. Mohan, N. Santhosh Kumar

Abstract


Background: The Portulaca oleracea belonging to portulacaceae family. It is a herbaceous plant widely distributed throughout the world and used in traditional medicine for many ailments. The present study was to evaluate the antinociceptive action of petroleum ether extract of P. oleracea in vincristine induced peripheral neuropathic pain and the possible mechanisms involved.

Methods: Peripheral neuropathy was induced in rats by administration of vincristine sulfate (50 μg/kg i.p.) for 10 consecutive days. The cold tail hyperalgesia was assessed by cold water tail immersion test. To identify the possible mechanisms involved in the antinociceptive action of petroleum ether extract of P. oleracea, acetic acid writhing method was employed. Mice were pretreated with naloxone, glibenclamide before petroleum ether extract treatment to identify the involvement of opioid and potassium channels, respectively.

Results: The administration of petroleum ether extract of P. oleracea (100 and 200 mg/kg p.o.) for 10 days significantly attenuated vincristine-induced cold hyperalgesia. Pre-treatment with glibenclamide reversed the antinociceptive effect of P. oleracea, but the naloxone pre-treatment did not reverse the antinociceptive activity of P. oleracea.

Conclusion: The results of the present study reveal the antinociceptive effect of P. oleracea in vincristine induced peripheral neuropathy and involving ATP-sensitive potassium channels pathway.


Keywords


Antinociceptive effect, Neuronal mechanisms, Petroleum ether extract

Full Text:

PDF

References


Rowinsky EK, Cazenave LA, Donehower RC. Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst. 1990;82(15):1247-59.

Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002;249(1):9-17.

Polomano RC, Mannes AJ, Clark US, Bennett GJ. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain. 2001;94(3):293-304.

Pascual D, Goicoechea C, Suardíaz M, Martín MI. A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats. Pain. 2005;118(1-2):23-34.

Matsumoto M, Inoue M, Hald A, Xie W, Ueda H. Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther. 2006;318(2):735-40.

Cata JP, Weng HR, Dougherty PM. The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res. 2008;1229:100-10.

Kawashiri T, Egashira N, Itoh Y, Shimazoe T, Ikegami Y, Yano T, et al. Neurotropin reverses paclitaxel-induced neuropathy without affecting anti-tumour efficacy. Eur J Cancer. 2009;45:154-63.

Flatters SJ, Xiao WH, Bennett GJ. Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neurosci Lett. 2006;397:219-23.

Ezekwe MO, Omara-Alwala TR, Membrahtu T. Nutritive characterization of purslane accessions as influenced by planting date. Plant Foods Hum Nutr. 1999;54(3):183-91.

Liu L, Howe P, Zhou YF, Xu ZQ, Hocart C, Zhan R. Fatty acids and beta-carotene in australian purslane (Portulaca oleracea) varieties. J Chromatogr A. 2000;893(1):207-13.

Barbosa-Filho JM, Alencar AA, Nunes XP, Tomaz AC, Sena Filho JG, Athayde Filho PF. Sources of alpha, beta, gamma, delta and epsilon-carotenes: a twentieth century review. Rev Bras Farmacogn. 2008;18:135-54.

Sakai NK, Okamoto, Shizuru Y, Fukuyama Y, Portuloside A. A monoterpene glucoside from Portulaca oleracea. Phytochemistry. 1996;42(6):1625-8.

Mizutani M, Hashidoko Y, Tahara S. Factors responsible for inhibiting the motility of zoospores of the phytopathogenic fungus Aphanomyces cochlioides isolated from the non-host plant Portulaca oleracea. FEBS Lett. 1998;438(3):236-40.

Prashanth KL, Jadav H, Thakurdesai P, Nagappa AN. The cosmetic potential of herbal extracts. Nat Prod Radiat. 2005;4(4):351.

Oh KB, Chang IM, Hwang KJ, Mar W. Detection of antifungal activity in Portulaca oleracea by a single-cell bioassay system. Phytother Res. 2000;14(5):329-32.

Verma OP, Kumar S, Chatterjee SN. Antifertility effects of common edible Portulaca oleracea on the reproductive organs of male albino mice. Indian J Med Res. 1982;75:301-10.

Parry O, Marks JA, Okwuasaba FK. The skeletal muscle relaxant action of Portulaca oleracea: role of potassium ions. J Ethnopharmacol. 1993;40(3):187-94.

Rashed AN, Afifi FU, Disi AM. Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1. J Ethnopharmacol. 2003;88(2-3):131-6.

Rao JN. Evaluation of the antinociceptive and antiinflammatory activities of the pet: ether extract of Portulaca oleracea (linn.). J Clin Diagn Res. 2012;3877:2002.

Mehta RM. Pharmaceutics 1: extraction processes; continuous soxhlet extraction; 2002: 157-8.

Siau C, Bennett GJ. Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth Analg. 2006;102(5):1485-90.

Necker R, Hellon RF. Noxious thermal input from the rat tail: modulation by descending inhibitory influences. Pain. 1978;4(3):231-42.

Rajendran NN, Thirugnanasambandam P, Viswanathan S, Parvathavarthini S, Ramaswamy S. Antinociceptive pattern of flavone and its mechanism as tested by formalin assay. Indian J Exp Biol. 2000;38(2):182-5.

Venkataramanan PE, Parvathavarthini S, Viswanathan S, Ramaswamy S. Role of ATP sensitive potassium channel on 7-hydroxy flavone induced antinociception and possible association with changes in glycaemic status. Indian J Exp Biol. 2000;38(11):1172-4.

Ito T, Mochida A, Saito K, Nishi K, Sasaki S, Hisada T, et al. An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years. Nihon Kokyuki Gakkai Zasshi. 2002;40(1):71-6.

Pal PK. Clinical and electrophysiological studies in vincristine induced neuropathy. Electromyogr Clin Neurophysiol. 1999;39(6):323-30.

McCarthy GM, Skillings JR. Jaw and other orofacial pain in patients receiving vincristine for the treatment of cancer. Oral Surg Oral Med Oral Pathol. 1992;74(3):299-304.

Jackson DV Jr., Sethi VS, Spurr CL, McWhorter JM. Pharmacokinetics of vincristine in the cerebrospinal fluid of humans. Cancer Res. 1981;41(4):1466-8.

Tanner KD, Levine JD, Topp KS. Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J Comp Neurol. 1998;395(4):481-92.

Topp KS, Tanner KD, Levine JD. Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. J Comp Neurol. 2000;424(4):563-76.

Du X, Wang C, Zhang H. Activation of ATP-sensitive potassium channels antagonize nociceptive behavior and hyperexcitability of DRG neurons from rats. Mol Pain. 2011;7:35.

Alves DP, Tatsuo MA, Leite R, Duarte ID. Diclofenac-induced peripheral antinociception is associated with ATP-sensitive K+ channels activation. Life Sci. 2004;74(20):2577-91.

Ocaña M, Baeyens JM. Differential effects of K+ channel blockers on antinociception induced by alpha 2-adrenoceptor, GABAB and kappa-opioid receptor agonists. Br J Pharmacol. 1993;110(3):1049-54.

Granados-Soto V, Argüelles CF, Ortiz MI. The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels. Neuropharmacology. 2002;43(5):917-23.